ArticleFrontiers in immunology2022

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.

Bernardo L Rapoport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.